Skip to main content

Advertisement

Log in

Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays

  • Research Articles
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Background and purpose

To evaluate the compliance of the prescribed OTT in a normal clinical practice and to establish the incidence, duration and causes of unplanned interruptions of radiation therapy. To quantify the impact of an institutional policy to maintain the OTT counteracting some short interruptions by treating patients on Saturday morning.

Material and methods

The treatment charts of all new patients treated with curative intent in a period of one year were reviewed retrospectively. All treatments started on Monday or Tuesday and split-course was not used. The difference between the actual realized and the planned OTT was calculated as a measure of compliance. Recalculations of OTT were made to quantify the impact of compensating short gaps by treating patients on Saturday. The cause of interruption was also recorded and classified.

Results

The charts of 478 consecutive patients treated with curative intent were reviewed. The overall incidence of unplanned interruptions was 76.6%. Public holidays and machine maintenance caused most of interruptions, and machine breakdown caused 13%. 17.9% of the interruptions were greater than 5 days and 5.6% greater than 10 days. Only 23.4% of patients finished their radiotherapy in the planned OTT (12.6% if no compensation on Saturday). 48.9% of head and neck cancer patients finished their treatment in the planned OTT (19.5% if no compensation on Saturday). The time in excess ranged up to 44 days, and the average time in excess was 3.3 days for the entire group (4.2 days if no compensation on Saturday). For head and neck cancer patients, the time in excess was 1.9 days (3.9 days if no compensation on Saturday).

Conclusions

This study has documented that the incidence and duration of unplanned interruptions of standard treatment schedules is a major problem in normal clinical practice. Most interruptions are short and due mainly to public holidays and machine maintenance and for these reasons they can be planned. In spite of the extra costs, counteracting some short interruptions by treating patients on Saturday is a good way to maintain the OTT without loss of local control.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Withers HR, Taylor JMG, Maciejewski B (1988) The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27:131–146

    Article  PubMed  CAS  Google Scholar 

  2. Budihna M, Skrk J, Smid L et al (1980) Tumor cell repopulation in the rest interval of split-course radiation treatment. Strahlentherapie 156:402–408

    PubMed  CAS  Google Scholar 

  3. Maciejewski B, Preuss-Bayer G, Trott KR (1983) The influence of the number of fractions and of overall treatment time on local control and late complications rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 9:321–328

    PubMed  CAS  Google Scholar 

  4. Bataini JP, Bernier J, Asselain B et al (1989) A multivariate primary tumor control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: clinical and treatment parameters as prognostic factors. Radiother Oncol 14:265–277

    Article  PubMed  CAS  Google Scholar 

  5. Taylor JMG, Withers HR, Mendenhall WM (1990) Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother Oncol 17:95–102

    Article  PubMed  CAS  Google Scholar 

  6. Bentzen SM, Johansen LV, Overgaard J et al (1991) Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 20:1197–1206

    PubMed  CAS  Google Scholar 

  7. Pajak TF, Laramore GE, Marcial VA et al (1991) Elapsed treatment days: a critical item for radiotherapy quality control review in head and neck trials-RTOG report. Int J Radiat Oncol Biol Phys 20:13–20

    PubMed  CAS  Google Scholar 

  8. Barton MB, Keane TJ, Gadalla T et al (1992) The effect of treatment time and treatment interruption on tumor control following radical radiotherapy of laryngeal cancer. Radiother Oncol 23:137–143

    Article  PubMed  CAS  Google Scholar 

  9. Rudoltz MS, Benammer A, Mohiuddin M (1993) Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Phys 26:767–772

    PubMed  CAS  Google Scholar 

  10. Withers HR, Peters LJ, Taylor JMG (1995) Local control of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys 33:549–562

    PubMed  CAS  Google Scholar 

  11. Duncan W, MacDougall RH, Kerr GR et al (1996) Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiother Oncol 41:203–207

    Article  PubMed  CAS  Google Scholar 

  12. Robertson C, Robertson AG, Hendry JH et al (1998) Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: a linear quadratic analysis. Radiother Oncol 48:165–173

    Article  PubMed  CAS  Google Scholar 

  13. Skladowski K, Law MG, Maciejewski B et al (1994) Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration. Radiother Oncol 30:109–120

    Article  PubMed  CAS  Google Scholar 

  14. Robertson C, Robertson AG, Hendry JH et al (1998) Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 40:319–329

    PubMed  CAS  Google Scholar 

  15. van der Voet JCM, Keus RB, Hart AAM et al (1998) The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys 42:247–255

    PubMed  Google Scholar 

  16. Tarnawski R, Fowler J, Skladowski K et al (2002) How fast is repopulation of tumor cells during the treatment gap? Int J Radiat Oncol Biol Phys 54:229–236

    PubMed  Google Scholar 

  17. Parsons JT, Bova FJ, Million RR (1980) A reevaluation of split-course tenique for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 6:1645–1652

    PubMed  CAS  Google Scholar 

  18. Overgaard M, Hjelm-Hansen M, Vendelbo JL et al (1988) Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol 27:147–161

    Article  PubMed  CAS  Google Scholar 

  19. Hoffstetter S, Marchal S, Peiffert D et al (1997) Treatment duration as a prognostic factor for local control and survival in epidermoid carcinoma of the tonsillar region treated by combined external beam irradiation and brachytherapy. Radiother Oncol 45:141–148

    Article  PubMed  CAS  Google Scholar 

  20. Hosowkawa Y, Shirato H, Nishioka T et al (2003) Effect of treatment time on outcome of radiotherapy for oral tongue carcinoma. Int J Radiat Oncol Biol Phys 57:71–78

    Google Scholar 

  21. Amdur RJ, Parson JT, Mendenhall WM et al (1989) Split-course versus continuous-course irradiation in the postoperative setting of squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 17:279–285

    PubMed  CAS  Google Scholar 

  22. Milecki P, Kruk-Zagajewska A, Szmeja Z et al (1997) The influence of the duration of a break in the course of post-operative radiotherapy on the results of treatment with total laryngectomy due to cancer. Otolaryngol Pol 51:37–46

    PubMed  CAS  Google Scholar 

  23. Langendijk JA, de Jong MA, Leemans ChR et al (2003) Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: the importance of the overall treatment time. Int J Radiat Oncol Biol Phys 57:693–700

    PubMed  CAS  Google Scholar 

  24. Alden ME, O’Reilly RC, Topham A et al (1996) Elapsed radiation therapy treatment time as a predictor of survival in patients with advanced head and neck cancer who receive chemotherapy and radiation therapy. Radiology 201:675–680

    PubMed  CAS  Google Scholar 

  25. Fowler JF, Lindstrom MJ (1992) Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 23:457–467

    PubMed  CAS  Google Scholar 

  26. Hendry JH, Bentzen SM, Dale RG et al (1996) A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol 8:297–307

    Article  CAS  Google Scholar 

  27. Fyles A, Keane TJ, Barton M, Simm J (1992) The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 25:273–279

    Article  PubMed  CAS  Google Scholar 

  28. Lanciano RM, Pajak TF, Martz K et al (1993) The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study. Int J Radiat Oncol Biol Phys 25:391–398

    PubMed  CAS  Google Scholar 

  29. Girinsky T, Rey A, Roche B et al (1993) Overall treatment time in advanced cervical carcinomas. A critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 27:1051–1056

    PubMed  CAS  Google Scholar 

  30. Petereit DG, Sarkaria JN, Chappell R et al (1995) The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 32:1301–1307

    PubMed  CAS  Google Scholar 

  31. Perez CA, Grigsby PW, Castro-Vita H et al (1995) Carcinoma of the uterine cervix. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 30:1275–1288

    Google Scholar 

  32. Fyles AW, Pintilie M, Kirkbride P et al (1995) Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother Oncol 35:107–117

    Article  PubMed  CAS  Google Scholar 

  33. Cox JD, Pajak TF, Marcial VA et al (1992) Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from RTOG Protocol 83-13. Cancer 69:2744–2748

    Article  PubMed  CAS  Google Scholar 

  34. Cox JD, Pajak TF, Asbell S et al (1993) Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys 27:493–498

    PubMed  CAS  Google Scholar 

  35. Chen M, Jiang GL, Fu XL et al (2000) The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer. Lung Cancer 28:11–19

    Article  PubMed  Google Scholar 

  36. Fowler JF, Chappell R (2000) Non-small cell lung tumors repopulate rapidly during radiation therapy. Int J Radiat Oncol Biol Phys 46:516–517

    Article  PubMed  CAS  Google Scholar 

  37. DelCharco JO, Bolek TW, McCollough WM et al (1998) Medulloblastoma: time-dose relationship based on a 30-year review. Int J Radiat Oncol Biol Phys 42:147–154

    CAS  Google Scholar 

  38. Taylor RE, Bailey CC, Robinson K et al (2003) Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: the International Society of Paediatric Oncology/United Kingdom Children’s Cancer Study Group PNET-3 study. J Clin Oncol 21:1581–1591

    Article  PubMed  CAS  Google Scholar 

  39. Constantinou EC, Daly W, Fung CY (1997) Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 39:651–657

    PubMed  CAS  Google Scholar 

  40. Ceresoli GL, Ferreri AJM, Corrido S et al (1998) Role of dose intensity in conservative treatment of anal canal carcinoma. Oncology 55:525–532

    Article  PubMed  CAS  Google Scholar 

  41. Weber DC, Kurtz JM, Allal AS (2001) The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 50:675–680

    PubMed  CAS  Google Scholar 

  42. Graf R, Wust P, Hildebrandt B et al (2002) The impact of overall treatment time on local control in anal cancer treatment with radiochemotherapy. 44th ASTRO Meeting. Int J Radiat Oncol Biol Phys 54[Suppl]:212

    Article  Google Scholar 

  43. Kajanti M, Kaleta R, Kankaanranta L et al (1995) Effect of overall treatment time on local control in radical radiotherapy for squamous cell carcinoma of esophagus. Int J Radiat Oncol Biol Phys 32:1017–1023

    PubMed  CAS  Google Scholar 

  44. Girinsky T, Auperin A, Marsiglia H et al (1997) Accelerated fractionation in esophageal cancers: a multivariate analysis on 88 patients. Int J Radiat Oncol Biol Phys 38:1013–1018

    PubMed  CAS  Google Scholar 

  45. Nishimura Y, Ono K, Tsutsui K et al (1994) Esophageal cancer treated with radiotherapy: impact of total treatment time and fractionation. Int J Radiat Oncol Biol Phys 30:1099–1105

    PubMed  CAS  Google Scholar 

  46. Lee WR, Marcus RB, Sombeck MD et al (1994) Radiotherapy alone for carcinoma of the vagina: The importance of overall treatment time. Int J Radiat Oncol Biol Phys 29:983–988

    PubMed  CAS  Google Scholar 

  47. Tomiak AT, Videtic GM, Stitt LW et al (2000) Treatment breaks caused by toxicity from concurrent chemoradiation for limited small cell lung cancer decrease survival and local control. Proceedings of the 42nd Annual ASTRO meeting. Int J Radiat Oncol Biol Phys 48:325–326

    Google Scholar 

  48. Mattews C, Bogart J, White D et al (2004) Split course versus continuous thoracic radiotherapy for limited stage small cell lung cancer: a randomized phase III trial. Proceedings of the ASTRO 46th Annual Meeting. Int J Radiat Oncol Biol Phys 60[Suppl 1]:S203

    Article  Google Scholar 

  49. Maciejewski B, Makewski S (1992) Dose fractionation and tumor repopulation in radiotherapy for bladder cancer. Radiother Oncol 21:163–170

    Article  Google Scholar 

  50. De Neve W, Lybeert MLM, Goor C et al (1995) Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time. Radiother Oncol 36:183–188

    Article  PubMed  Google Scholar 

  51. Moneen L, Voet HVD, de Nijs R et al (1998) Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control. Int J Radiat Oncol Biol Phys 42: 525–530

    Google Scholar 

  52. Lai PP, Shapiro SJ, Perez CA (1989) Carcinoma of the prostate stage B and C: influence of duration of radiotherapy. Int J Radiat Oncol Biol Phys 17[Suppl 1]:164

    Google Scholar 

  53. Lai PP, Perez CA, Shapiro SJ et al (1990) Carcinoma of the prostate stage B and C. Lack of influence of duration of radiotherapy on tumor control and treatment morbidity. Int J Radiat Oncol Biol Phys 19:561–568

    PubMed  CAS  Google Scholar 

  54. Lai PP, Pilepich MV, Krall JM et al (1991) The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 experience. Int J Radiat Oncol Biol Phys 21:925–933

    PubMed  CAS  Google Scholar 

  55. Amdur RJ, Parsons JT, Fitzgerald LT et al (1990) The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapy. Int J Radiat Oncol Biol Phys 19:1377–1382

    PubMed  CAS  Google Scholar 

  56. Lindberg RD, Jones K, Garner HH et al (1988) Evaluation of unplanned interruptions in radiotherapy treatment schedules. Int J Radiat Oncol Biol Phys 14:811–815

    PubMed  CAS  Google Scholar 

  57. Khalil AA, Bentzen SM, Bernier J et al (2000) Compliance to the prescribed overall treatment time in five randomised controlled trials of altered radiotherapy fractionation in patients with squamous cell carcinoma of the head and neck. 19th Annual ESTRO Meeting. Radiother Oncol 6[Suppl 1]:S12

    Google Scholar 

  58. Board of Faculty of Clinical Oncology. The Royal College of Radiologists (2002) Guidelines for the management of the unscheduled interruption or prolongation of a radical course of radiotherapy, 2nd Edn. http://www.rcr.ac.uk

  59. Thames HD, Bentzen SM, Turesson I et al (1990) Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol 19:219–235

    Article  PubMed  CAS  Google Scholar 

  60. Harari PM, Fowler JF (1994) Idealized versus realized overall treatment times. Int J Radiat Oncol Biol Phys 29:209–211

    PubMed  CAS  Google Scholar 

  61. Yaes RJ (1995) Some common causes of treatment prolongation. Int J Radiat Oncol Biol Phys 31:686–687

    PubMed  CAS  Google Scholar 

  62. Roberts SA, Hendry JH (1999) Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centres. Int J Radiat Oncol Biol Phys 45:1247–1257

    Article  PubMed  CAS  Google Scholar 

  63. Hermann T, Jakubek A, Trott KR (1994) The importance of the timing of a split in radiotherapy of squamous cell carcinomas of the head and neck. Strahlenther Onkol 170:545–549

    Google Scholar 

  64. Hendry JH, Mackay RI, Roberts SA, Slevin NJ (1998) Outstanding issues in radiation dose-fractionation studies. Int J Radiat Biol 4:383–394

    Google Scholar 

  65. Wendt TG, Grabenbauer GG, Rödel CM et al (1998) Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 16:1318–1324

    PubMed  CAS  Google Scholar 

  66. Wong WW, Mick R, Haraf DJ et al (1994) Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer. Int J Radiat Oncol Biol Phys 29:153–162

    PubMed  CAS  Google Scholar 

  67. Tomiak AT, Videtic GM, Stitt LW et al (2000) Treatment breaks caused by toxicity from concurrent chemoradiation for limited small cell lung cancer decrease survival and local control. Proceedings of the 42nd Annual ASTRO Meeting. Int J Radiat Oncol Biol Phys 48:S325–326

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Miquel Maciá i Garau.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maciá i Garau, M., Solé Monné, J., Cambra Serés, M.J. et al. Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays. Clin Transl Oncol 11, 302–311 (2009). https://doi.org/10.1007/s12094-009-0358-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-009-0358-2

Keywords

Navigation